Alnylam Pharmaceuticals

+$2.26 (+1.23%) As of 2:55 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO
John M. Maraganore
Employees
1,453
Headquarters
Cambridge, Massachusetts
Founded
2002

ALNY Key Statistics

Market Cap
22.07B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
493.40K
High Today
$186.99
Low Today
$184.45
Open Price
$184.54
Volume
263.38K
52 Week High
$209.73
52 Week Low
$119.29

ALNY News

Simply Wall StSep 20

Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. By 49%?

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Alnylam Pharmaceuticals, Inc. ( ) as an investment opportunity

ALNY Earnings

-$2.23
-$1.49
-$0.74
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure